A Phase III, Double-Blind, Placebo-Controlled, Randomized Study Of Ipatasertib In Combination With Atezolizumab And Paclitaxel As A Treatment For Patients With Locally Advanced Unresectable Or Metastatic Triple-Negative Breast Cancer
- Kefford, Richard (Primary Chief Investigator)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Parshionikar, Abhijit (Clinical Trial Unit Staff)
- Rajasekharan Nair, Archana (Clinical Trial Unit Staff)
Project: Other